Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> InnoCare Pharma (09969.HK) 1Q26 Net Profit RMB106 million, Up 4.9x
Recommend 4 Positive 6 Negative 1 |
||||
|
||||
|
InnoCare Pharma (09969.HK) (688428.SH) announced its first-quarter results. Under the China Accounting Standards, revenue amounted to RMB529 million, up 38.7% YoY. Net profit attributable to shareholders reached RMB106 million, surging 488.9% YoY, with EPS of RMB0.06. (de/d) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
